Fibromyalgianess and glucocorticoid persistence among patients with rheumatoid arthritis.
Wallace BI, Moore MN, Heisler AC, Muhammad LN, Song J, Clauw DJ, Bingham CO, Bolster MB, Marder W, Neogi T, Wohlfahrt A, Dunlop DD, Lee YC.
Wallace BI, et al.
Rheumatology (Oxford). 2022 Apr 11;61(4):1556-1562. doi: 10.1093/rheumatology/keab583.
Rheumatology (Oxford). 2022.
PMID: 34293092
Free PMC article.
OBJECTIVES: Over one-third of patients with RA exhibit evidence of fibromyalgianess, which is associated with higher rates of disability and inadequate responsiveness to RA treatment. Patients with RA often remain on glucocorticoids long-term, despite the known risk of dos …
OBJECTIVES: Over one-third of patients with RA exhibit evidence of fibromyalgianess, which is associated with higher rates of disability and …